Hudson Bay Capital Management »

Neurosense Therapeutics shares owned by Hudson Bay Capital Management

Quarter-by-quarter ownership of Neurosense Therapeutics (NRSNW) shares owned by Hudson Bay Capital Management from 13F filings

Historical chart of Hudson Bay Capital Management investment in Neurosense Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Neurosense Therapeutics held by Hudson Bay Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neurosense Therapeutics by Hudson Bay Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $36k 87k 0.42
2023-12-31 $8.7k 87k 0.10
2023-09-30 $14k 87k 0.16
2023-06-30 $21k 88k 0.24
2023-03-31 $45k 150k 0.30
2022-12-31 $30k 150k 0.20
2022-06-30 $81k 150k 0.54
2022-03-31 $90k 150k 0.60
2021-12-31 $137k 150k 0.91

More positions owned by Hudson Bay Capital Management

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Microsoft Corporation Put Option (MSFT)
NVIDIA Corporation Call Option (NVDA)
Amazon Call Option (AMZN)
Apple Put Option (AAPL)
Alphabet Cap Stk Cl C Put Option (GOOG)
Meta Platforms Cl A Put Option (META)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Tesla Motors Put Option (TSLA)
Advanced Micro Devices Put Option (AMD)
Ishares Tr Msci Acwi Etf Put Option (ACWI)
Berkshire Hathaway Inc Del Cl B New Put Option (BRK.B)
Alphabet Cap Stk Cl A Put Option (GOOGL)
Pioneer Natural Resources Put Option (PXD)
Royal Caribbean Group Note 6.000% 8/1 (Principal)

View all positions for Hudson Bay Capital Management

Top funds holding Neurosense Therapeutics

Hudson Bay Capital Management
Clear Street
Citadel Advisors
Warberg Asset Management

View all funds holding Neurosense Therapeutics